PeptideDB

5-Acetylsalicylic acid 13110-96-8

5-Acetylsalicylic acid 13110-96-8

CAS No.: 13110-96-8

5-Acetylsalicylic acid has anti~inflammatory effects and is considered an active agent in inflammatory bowel disease (IB
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

5-Acetylsalicylic acid has anti~inflammatory effects and is considered an active agent in inflammatory bowel disease (IBD).

Physicochemical Properties


Molecular Formula C9H8O4
Molecular Weight 180.15742
Exact Mass 180.042
CAS # 13110-96-8
PubChem CID 83151
Appearance Typically exists as solid at room temperature
Density 1.365 g/cm3
Boiling Point 413ºC at 760 mmHg
Melting Point 214-216°C
Flash Point 250°C
Vapour Pressure 1.46E-07mmHg at 25°C
LogP 1.293
Hydrogen Bond Donor Count 2
Hydrogen Bond Acceptor Count 4
Rotatable Bond Count 2
Heavy Atom Count 13
Complexity 224
Defined Atom Stereocenter Count 0
SMILES

CC(=O)C1=CC(=C(C=C1)O)C(=O)O

InChi Key NZRDKNBIPVLNHA-UHFFFAOYSA-N
InChi Code

InChI=1S/C9H8O4/c1-5(10)6-2-3-8(11)7(4-6)9(12)13/h2-4,11H,1H3,(H,12,13)
Chemical Name

5-acetyl-2-hydroxybenzoic acid
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


Additional Infomation 5-Acetylsalicylic acid is an aromatic ketone.

Solubility Data


Solubility (In Vitro) DMSO : ~100 mg/mL (~555.06 mM)
Solubility (In Vivo) Solubility in Formulation 1: ≥ 2.5 mg/mL (13.88 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL.
Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.

Solubility in Formulation 2: ≥ 2.5 mg/mL (13.88 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.

Solubility in Formulation 3: ≥ 2.5 mg/mL (13.88 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 5.5506 mL 27.7531 mL 55.5062 mL
5 mM 1.1101 mL 5.5506 mL 11.1012 mL
10 mM 0.5551 mL 2.7753 mL 5.5506 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.